Ana A. Weil, MD, MPH | Allergy and Infectious Diseases

Acting Instructor

Department of Medicine, Division of Allergy & Infectious Diseases

Faculty Information

Biography

Dr. Ana Weil studies the relationship between the gut microbiome and immune responses to enteric diseases. Using molecular, genomic and immunologic methods, she investigates how the gut microbiome influences susceptibility to enteric infections, modulation of immune responses by the gut microbiome, and pathogen-gut microbe interactions at the mucosal surface.

She works with several US-based collaborators and the International Centre for Diarrhoeal Disease Research, Bangladesh.

Education & Training:

MPH

Johns Hopkins University School of Public Health

Baltimore MD

2004

Tufts University School of Medicine

Medford MA

2010

Residency

Massachusetts General Hospital

Bostom MA

2013

Fellowship

Massachusetts General Hospital

Boston MA

2015

Honors:

Fulbright Scholar, Malawi

2001

Fogarty/NIH Clinical Scholar, International Center for Diarrheal Disease Research, Bangaldesh

2007

William Damesheck Research Award, Tufts Medical School

2010

Edward H. Kass Award for Excellence in Research, Infectious Disease Society of America

2012

Edward H. Kass Award for Clinical Excellence, Massachusetts Infectious Disease Society

2014

Chief Resident, Department of Medicine, Massachusetts General Hospital

2015-2016

ID Week Abstract Committee Choice Award, ID Week Program Committee

2015

Morton N. Swartz Professional Development Award, Division of Infectious Diseases, MGH

2018

Contact

Email:

anaweil@uw.edu

Mailing Address:

750 Republican Street, Room E607, Seattle, WA 98109

Research & Clinical Interests

Research Interests:

Enteric disease and the gut microbiome
Immune responses to Vibrio cholerae infection
Responses to oral cholera vaccines
Enteroid models of disease
Host-pathogen interactions at the mucosal surface

Publications

PubMed:

PubMed Bibliography

Publications:

Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT. Estimating cholera incidence with cross-sectional serology. Science translational medicine. 2019; 11(480).
• PubMed Abstract

Ritter AS, Chowdhury F, Franke MF, Becker RL, Bhuiyan TR, Khan AI, Saha NC, Ryan ET, Calderwood SB, LaRocque RC, Harris JB, Qadri F, Weil AA. Vibriocidal Titer and Protection From Cholera in Children, Open Forum Infectious Diseases. 2019 April; 6(4):ofz057.
• PubMed Abstract

Midani FS*, Weil AA*, Chowdhury F, Begum YA, Khan AI, Debela MD, Durand HK, Reese AT, Nimmagadda SN, Silverman JD, Ellis CN, Ryan ET, Calderwood SB, Harris JB, Qadri F, David LA, LaRocque RC. Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection. The Journal of Infectious Diseases. 2018; 218(4):645-653. * Co-first authors.
• PubMed Abstract

David LA, Weil AA, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ. Gut Microbial Succession Follows Acute Secretory Diarrhea in Humans. MBio. 2015 May 19; 6(3):e00381-15.
• PubMed Abstract

Weil AA, Begum Y, Chowdhury F, Khan AI, Leung DT, LaRocque RC, Charles RC, Ryan ET, Calderwood SB, Qadri F, Harris JB. Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. Am Journal Trop Med Hyg. 2014 Oct; 91(4)738-42.
• PubMed Abstract

Printer-friendly